文献速递慢性肾脏病

CKD进展的种族差异:CRIC与KNOW-CKD队列比较研究

Ethnic Disparities in CKD Progression: A Comparative Study of CRIC and KNOW-CKD Cohorts.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-11-11

本研究比较了韩国KNOW-CKD与美国CRIC队列共4953例CKD患者,发现KNOW-CKD组CKD进展风险显著高于CRIC组(HR 1.66),年eGFR下降更陡(-2.51 vs -1.14 ml/min/1.73m2),但全因死亡风险显著更低(HR 0.51)。两个队列中的亚洲参与者eGFR下降斜率相似。

要点

  • 韩国CKD队列进展风险高于美国队列,但死亡风险更低。
  • 亚洲参与者eGFR下降斜率相似,且陡于黑人和白人。
  • 需针对种族差异制定CKD管理策略。

核心结论

  • 韩国队列CKD进展快于美国队列,但死亡风险更低,提示疾病进展与生存存在种族或地区差异。

研究设计与样本

  • 比较韩国KNOW-CKD与美国CRIC两个全国性队列,共纳入4953例参与者(CRIC占69%,KNOW-CKD占31%)。

主要发现

  • KNOW-CKD组CKD进展发生1285例,CRIC组570例,发生率分别为67.9和41.7/1000人年。
  • KNOW-CKD相比CRIC的CKD进展风险比为1.66(95%CI 1.45-1.89)。
  • KNOW-CKD组年eGFR下降为-2.51 ml/min/1.73m2,CRIC组为-1.14 ml/min/1.73m2。
  • CRIC中亚洲参与者eGFR斜率为-2.10(95%CI -2.69至-1.52),KNOW-CKD为-2.50(95%CI -2.67至-1.52),黑人为-1.47(-1.61至-1.33),白人为-0.81(-0.92至-0.70)ml/min/1.73m2/年。
  • KNOW-CKD组全因死亡风险显著低于CRIC组(HR 0.51,95%CI 0.38-0.68)。

临床怎么用

  • 临床中应考虑种族差异对CKD进展和死亡风险的影响,对亚洲CKD患者加强进展监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Risk of all-cause mortality was significantly lower in KoreaN Cohort Study for Outcome in Patients with CKD group than that in the Chronic Renal Insufficiency Cohort group. Asian cohorts exhibited steeper eGFR decline slopes than that of the Black and White cohorts. Tailored clinical approaches and ethnicity-stratified studies are required to improve CKD management. BACKGROUND: Ethnic differences in CKD progression remain understudied, particularly between Asian and Western populations. Therefore, we aimed to investigate ethnic disparities in CKD progression by comparing nationwide cohorts from South Korea (the KoreaN Cohort Study for Outcome in Patients with CKD [KNOW-CKD]) and the United States (the US Chronic Renal Insufficiency Cohort [CRIC]). METHODS: A total of 4953 participants were included (69% from CRIC and 31% from KNOW-CKD). The primary outcome was CKD progression, defined as a 50% or greater decline of eGFR or kidney failure requiring KRT. In the secondary outcome analysis, we compared eGFR decline rates and all-cause mortality. RESULTS: Of the 4953 participants, CKD progression occurred in 1285 and 570 in the KNOW-CKD and CRIC cohorts, with incidence rates of 67.9 and 41.7 per 1000 person-years, respectively. The hazard ratio for the KNOW-CKD compared with CRIC was 1.66 (95% confidence interval [CI], 1.45 to 1.89). The annual eGFR decline was steeper in KNOW-CKD participants than in CRIC participants (−2.51 versus −1.14 ml/min per 1.73 m2). Asian participants from the CRIC cohort exhibited a similar eGFR slope (95% CIs) (−2.10 [−2.69 to −1.52]) to those from KNOW-CKD (−2.50 [−2.67 to −1.52]), while the slope was −1.47 (−1.61 to −1.33) and −0.81 (−0.92 to −0.70) ml/min per 1.73 m2 per year for Black and White participants, respectively. However, the risk of mortality was significantly lower in KNOW-CKD participants compared with CRIC participants (hazard ratio, 0.51; 95% CI, 0.38 to 0.68). CONCLUSIONS: CKD progression was faster in the Korean cohort than in the US cohort, with Asian participants in both cohorts showing similar eGFR decline rates. However, the Korean cohort had a lower risk of mortality, indicating potential ethnic or regional differences in disease progression and survival.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ko B, Jung CY, Ko YE, et al. Ethnic Disparities in CKD Progression: A Comparative Study of CRIC and KNOW-CKD Cohorts. Clin J Am Soc Nephrol. 2025. PMID: 41217835. doi:10.2215/CJN.0000000884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。